Dr.-Ing. Joscha Brinkmann
excipients, which further enhance the API solubility in the LBDDS or avoid API precipitation in the GIT[1, 2]. LBDDS are currently developed with high experimental effort via trial-and-error procedures, ending [...] and self-microemulsifying drug delivery systems" European Journal of Pharmaceutical Sciences , 2000 [2] C. W. Pouton: "Formulation of poorly water-soluble drugs for oral administration: Physicochemical and …
